Related Experiment Videos

Efforts towards a precision medicine approach in juvenile idiopathic arthritis

C Chew1,2,3, G W Jones1, A P Croft4,5

  • 1School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.

Rheumatology (Oxford, England)
|August 6, 2026
PubMed

Insights

Biomarkers are needed to personalize treatment for children with juvenile idiopathic arthritis (JIA). Multimodal data integration using computational methods can advance precision medicine for JIA patients.

Area of Science:

  • Rheumatology
  • Genomics
  • Computational Biology

Background:

  • Juvenile idiopathic arthritis (JIA) is the most frequent childhood arthritis, affecting children and young people (CYP).
  • Despite advanced treatments, many CYP with JIA face disease flares and chronic joint damage.
  • Current treatment strategies lack biomarkers for predicting therapeutic response.

Purpose of the Study:

  • To highlight the need for tailored treatment approaches in JIA based on individual biological profiles.
  • To explore the potential of single-cell technologies for detailed disease analysis.
  • To summarize strategies for integrating multimodal data to advance precision medicine in JIA.

Main Methods:

  • Utilizing advances in single-cell technologies to profile genes and proteins in target tissues.
  • Applying computational and machine learning methods for complex data analysis.
  • Integrating biological and clinical outcome data from large, diverse patient datasets.

Main Results:

  • Single-cell technologies offer unprecedented resolution for defining disease biology.
  • Computational approaches enable the analysis of complex, multimodal datasets.
  • Data integration strategies are crucial for maximizing precision medicine.

Conclusions:

  • Precision medicine approaches are essential for improving outcomes in CYP with JIA.
  • Multimodal data integration is key to identifying predictive biomarkers and guiding treatment.
  • Further research priorities should focus on leveraging these technologies for JIA management.

Keywords:
bioinformaticsbiological therapiesbiomarkersfunctional genomicsimmunologyinflammationjuvenile idiopathic arthritismicroarrays/gene expression profiling/transcriptomeproteomicssynovium

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...